Alta, Rowena O.
HRN: 18-43-49 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2025
CEFTAZIDIME 1GM (VIAL)
05/28/2025
06/03/2025
IV
2g
Q8h
CAPMR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: No Wrong Choice Reserved For Pseudomonas Coverage And Not Routinely Used For Moderate Risk CAP
Final appropriateness: Yes
Overall appropriateness: Yes